<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38747003</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 induces blood-brain barrier and choroid plexus barrier impairments and vascular inflammation in mice.</ArticleTitle><Pagination><StartPage>e29671</StartPage><MedlinePgn>e29671</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.29671</ELocationID><Abstract><AbstractText>The coronavirus disease of 2019 (COVID-19) pandemic has led to more than 700 million confirmed cases and nearly 7 million deaths. Although severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus mainly infects the respiratory system, neurological complications are widely reported in both acute infection and long-COVID cases. Despite the success of vaccines and antiviral treatments, neuroinvasiveness of SARS-CoV-2 remains an important question, which is also centered on the mystery of whether the virus is capable of breaching the barriers into the central nervous system. By studying the K18-hACE2 infection model, we observed clear evidence of microvascular damage and breakdown of the blood-brain barrier (BBB). Mechanistically, SARS-CoV-2 infection caused pericyte damage, tight junction loss, endothelial activation and vascular inflammation, which together drive microvascular injury and BBB impairment. In addition, the blood-cerebrospinal fluid barrier at the choroid plexus was also impaired after infection. Therefore, cerebrovascular and choroid plexus dysfunctions are important aspects of COVID-19 and may contribute to neurological complications both acutely and in long COVID.</AbstractText><CopyrightInformation>&#xa9; 2024 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qiao</LastName><ForeName>Haowen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Neurodegeneration and Regeneration, Zilkha Neurogenetic Institute, Department of Physiology and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Xiangxue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Lingxi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Yafei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center for Neurodegeneration and Regeneration, Zilkha Neurogenetic Institute, Department of Physiology and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiu</LastName><ForeName>Yuanpu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center for Neurodegeneration and Regeneration, Zilkha Neurogenetic Institute, Department of Physiology and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Feixiang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center for Neurodegeneration and Regeneration, Zilkha Neurogenetic Institute, Department of Physiology and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Shangzhou</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Neurodegeneration and Regeneration, Zilkha Neurogenetic Institute, Department of Physiology and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Graduate Program, University of Southern California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muenzel</LastName><ForeName>Cheyene</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Neurodegeneration and Regeneration, Zilkha Neurogenetic Institute, Department of Physiology and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Tenghuan</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center for Neurodegeneration and Regeneration, Zilkha Neurogenetic Institute, Department of Physiology and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zixin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Center for Neurodegeneration and Regeneration, Zilkha Neurogenetic Institute, Department of Physiology and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Pengfei</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Electrical and Computer Engineering, the Department of Bioengineering, Beckman Institute for Advanced Science and Technology, University of Illinois Urbana-Champaign, Urbana, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonnin</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Neurodegeneration and Regeneration, Zilkha Neurogenetic Institute, Department of Physiology and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Center for Neurodegeneration and Regeneration, Zilkha Neurogenetic Institute, Department of Physiology and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Graduate Program, University of Southern California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Weiming</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>W. M. Keck Foundation</Agency><Country/></Grant><Grant><GrantID>R01 AG061288</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS122060</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI149365</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><Agency>Infectious Diseases Society of America</Agency><Country/></Grant><Grant><GrantID>R56 AG082361</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS110687</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><Agency>National Institute of Allergy and Infectious Diseases</Agency><Country/></Grant><Grant><GrantID>R01 NS126981</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001812" MajorTopicYN="Y">Blood-Brain Barrier</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002831" MajorTopicYN="Y">Choroid Plexus</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019108" MajorTopicYN="N">Tight Junctions</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020286" MajorTopicYN="N">Pericytes</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS&#x2010;CoV&#x2010;2</Keyword><Keyword MajorTopicYN="N">blood&#x2010;brain barrier</Keyword><Keyword MajorTopicYN="N">choroid plexus barrier</Keyword><Keyword MajorTopicYN="N">mouse modeling</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">severe COVID</Keyword></KeywordList><CoiStatement>Conflict of interest and Data availability statement: The authors do not have any conflict of interests to declare. All data needed to evaluate the conclusions in the paper were present in the paper and/or Supporting information. The data that support the findings of this study are available from the corresponding author upon reasonable request.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>4</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38747003</ArticleId><ArticleId IdType="mid">NIHMS2023083</ArticleId><ArticleId IdType="pmc">PMC11446308</ArticleId><ArticleId IdType="doi">10.1002/jmv.29671</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gavriatopoulou M, Korompoki E, Fotiou D, Ntanasis-Stathopoulos I, Psaltopoulou T, Kastritis E, Terpos E, and Dimopoulos MA (2020). Organ-specific manifestations of COVID-19 infection. Clin Exp Med 20, 493&#x2013;506. 10.1007/s10238-020-00648-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-020-00648-x</ArticleId><ArticleId IdType="pmc">PMC7383117</ArticleId><ArticleId IdType="pubmed">32720223</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, Sultan M, Easton A, Breen G, Zandi M, et al. (2020). Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. The Lancet Psychiatry 7, 875&#x2013;882. 10.1016/S2215-0366(20)30287-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30287-X</ArticleId><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta V, Banavara Rajanna L, Upadhyay K, Bhatia R, Madhav Reddy N, Malik D, and Srivastava A (2021). Olfactory and Gustatory Dysfunction in COVID-19 Patients from Northern India: A Cross-Sectional Observational Study. Indian J Otolaryngol Head Neck Surg 73, 218&#x2013;225. 10.1007/s12070-021-02391-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12070-021-02391-5</ArticleId><ArticleId IdType="pmc">PMC7875162</ArticleId><ArticleId IdType="pubmed">33589874</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, et al. (2020). Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 77, 683. 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Munipalli B, Seim L, Dawson NL, Knight D, and Dabrh AMA (2022). Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management. SN Compr. Clin. Med 4, 90. 10.1007/s42399-022-01167-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-022-01167-4</ArticleId><ArticleId IdType="pmc">PMC8977184</ArticleId><ArticleId IdType="pubmed">35402784</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmazny A, Magdy R, Hussein M, Elsebaie EH, Ali SH, Abdel Fattah AM, Hassan M, Yassin A, Mahfouz NA, Elsayed RM, et al. (2023). Neuropsychiatric post-acute sequelae of COVID-19: prevalence, severity, and impact of vaccination. Eur Arch Psychiatry Clin Neurosci 273, 1349&#x2013;1358. 10.1007/s00406-023-01557-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-023-01557-2</ArticleId><ArticleId IdType="pmc">PMC9882743</ArticleId><ArticleId IdType="pubmed">36707454</ArticleId></ArticleIdList></Reference><Reference><Citation>Shariff S, Uwishema O, Mizero J, Devi Thambi V, Nazir A, Mahmoud A, Kaushik I, Khayat S, Yusif Maigoro A, Awde S, et al. (2023). Long-term cognitive dysfunction after the COVID-19 pandemic: a narrative review. Annals of Medicine &amp; Surgery 85, 5504&#x2013;5510. 10.1097/MS9.0000000000001265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MS9.0000000000001265</ArticleId><ArticleId IdType="pmc">PMC10617879</ArticleId><ArticleId IdType="pubmed">37915705</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross EC, Olivera GC, and Barragan A (2022). Early passage of Toxoplasma gondii across the blood&#x2013;brain barrier. Trends in Parasitology 38, 450&#x2013;461. 10.1016/j.pt.2022.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pt.2022.02.003</ArticleId><ArticleId IdType="pubmed">35227615</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Guennec L, Coureuil M, Nassif X, and Bourdoulous S (2020). Strategies used by bacterial pathogens to cross the blood&#x2013;brain barrier. Cellular Microbiology 22. 10.1111/cmi.13132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cmi.13132</ArticleId><ArticleId IdType="pubmed">31658405</ArticleId></ArticleIdList></Reference><Reference><Citation>Leda AR, Bertrand L, Andras IE, El-Hage N, Nair M, and Toborek M (2019). Selective Disruption of the Blood&#x2013;Brain Barrier by Zika Virus. Front. Microbiol 10, 2158. 10.3389/fmicb.2019.02158.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.02158</ArticleId><ArticleId IdType="pmc">PMC6759472</ArticleId><ArticleId IdType="pubmed">31620112</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X, Hussain B, and Chang J (2021). Peripheral inflammation and blood&#x2013;brain barrier disruption: effects and mechanisms. CNS Neurosci Ther 27, 36&#x2013;47. 10.1111/cns.13569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13569</ArticleId><ArticleId IdType="pmc">PMC7804893</ArticleId><ArticleId IdType="pubmed">33381913</ArticleId></ArticleIdList></Reference><Reference><Citation>Patabendige A, and Janigro D (2023). The role of the blood&#x2013;brain barrier during neurological disease and infection. Biochemical Society Transactions 51, 613&#x2013;626. 10.1042/BST20220830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20220830</ArticleId><ArticleId IdType="pmc">PMC10212550</ArticleId><ArticleId IdType="pubmed">36929707</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M-H, Perl DP, Nair G, Li W, Maric D, Murray H, Dodd SJ, Koretsky AP, Watts JA, Cheung V, et al. (2021). Microvascular Injury in the Brains of Patients with Covid-19. N Engl J Med 384, 481&#x2013;483. 10.1056/NEJMc2033369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2033369</ArticleId><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogrig A, Gigli GL, Bn&#xe0; C, and Morassi M (2021). Stroke in patients with COVID-19: Clinical and neuroimaging characteristics. Neuroscience Letters 743, 135564. 10.1016/j.neulet.2020.135564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2020.135564</ArticleId><ArticleId IdType="pmc">PMC7749733</ArticleId><ArticleId IdType="pubmed">33352277</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Re V, Dutcher SK, Connolly JG, Perez-Vilar S, Carbonari DM, DeFor TA, Djibo DA, Harrington LB, Hou L, Hennessy S, et al. (2022). Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients. JAMA 328, 637. 10.1001/jama.2022.13072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.13072</ArticleId><ArticleId IdType="pmc">PMC9382447</ArticleId><ArticleId IdType="pubmed">35972486</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly SR, Nguyen AV, Zhang Y, Feng D, and Huang JH (2021). The relationship between COVID-19 infection and intracranial hemorrhage: A systematic review. Brain Hemorrhages 2, 141&#x2013;150. 10.1016/j.hest.2021.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hest.2021.11.003</ArticleId><ArticleId IdType="pmc">PMC8582085</ArticleId><ArticleId IdType="pubmed">34786548</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MA, Cavestro C, Alam SS, Kundu S, Kamal MA, and Reza F (2022). Encephalitis in Patients with COVID-19: A Systematic Evidence-Based Analysis. Cells 11, 2575. 10.3390/cells11162575.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11162575</ArticleId><ArticleId IdType="pmc">PMC9406394</ArticleId><ArticleId IdType="pubmed">36010650</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson D, Brissette CA, and Watt JA (2022). The choroid plexus and its role in the pathogenesis of neurological infections. Fluids Barriers CNS 19, 75. 10.1186/s12987-022-00372-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-022-00372-6</ArticleId><ArticleId IdType="pmc">PMC9463972</ArticleId><ArticleId IdType="pubmed">36088417</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayub M, Jin HK, and Bae J (2021). The blood cerebrospinal fluid barrier orchestrates immunosurveillance, immunoprotection, and immunopathology in the central nervous system. BMB Rep. 54, 196&#x2013;202. 10.5483/BMBRep.2021.54.4.205.</Citation><ArticleIdList><ArticleId IdType="doi">10.5483/BMBRep.2021.54.4.205</ArticleId><ArticleId IdType="pmc">PMC8093941</ArticleId><ArticleId IdType="pubmed">33298242</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Zhou L, Bao L, Liu J, Zhu H, Lv Q, Liu R, Chen W, Tong W, Wei Q, et al. (2021). SARS-CoV-2 crosses the blood&#x2013;brain barrier accompanied with basement membrane disruption without tight junctions alteration. Sig Transduct Target Ther 6, 337. 10.1038/s41392-021-00719-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00719-9</ArticleId><ArticleId IdType="pmc">PMC8419672</ArticleId><ArticleId IdType="pubmed">34489403</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini L, Albecka A, Mallery DL, Kellner MJ, Paul D, Carter AP, James LC, and Lancaster MA (2020). SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids. Cell Stem Cell 27, 951&#x2013;961.e5. 10.1016/j.stem.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7553118</ArticleId><ArticleId IdType="pubmed">33113348</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao L, Deng W, Huang B, Gao H, Liu J, Ren L, Wei Q, Yu P, Xu Y, Qi F, et al. (2020). The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature 583, 830&#x2013;833. 10.1038/s41586-020-2312-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2312-y</ArticleId><ArticleId IdType="pubmed">32380511</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H, Liu Z, Deng X, Chen S, Zhou R, Zhao R, Parandaman R, Thind A, Henley J, Tian L, et al. (2023). Potent NKT cell ligands overcome SARS-CoV-2 immune evasion to mitigate viral pathogenesis in mouse models. PLoS Pathog 19, e1011240. 10.1371/journal.ppat.1011240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011240</ArticleId><ArticleId IdType="pmc">PMC10128965</ArticleId><ArticleId IdType="pubmed">36961850</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Zeng J, Pluimer B, Dong S, Xie X, Guo X, Liang X, Feng S, Wu H, Yan Y, et al. (2020). Microvascular Injury in Mild Traumatic Brain Injury Accelerates Alzheimer-like Pathogenesis in Mice (Neuroscience) 10.1101/2020.04.12.036392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.12.036392</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X, Ma G, Li X, Zhao J, Zhao Z, and Zeng J (2023). Activation of innate immune cGAS-STING pathway contributes to Alzheimer&#x2019;s pathogenesis in 5&#xd7;FAD mice. Nat Aging 3, 202&#x2013;212. 10.1038/s43587-022-00337-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-022-00337-2</ArticleId><ArticleId IdType="pubmed">37118112</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S-H, Chen Q, Gu H-J, Yang G, Wang Y-X, Huang X-Y, Liu S-S, Zhang N-N, Li X-F, Xiong R, et al. (2020). A Mouse Model of SARS-CoV-2 Infection and Pathogenesis. Cell Host &amp; Microbe 28, 124&#x2013;133.e4. 10.1016/j.chom.2020.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.05.020</ArticleId><ArticleId IdType="pmc">PMC7250783</ArticleId><ArticleId IdType="pubmed">32485164</ArticleId></ArticleIdList></Reference><Reference><Citation>Tietz S, and Engelhardt B (2015). Brain barriers: Crosstalk between complex tight junctions and adherens junctions. Journal of Cell Biology 209, 493&#x2013;506. 10.1083/jcb.201412147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201412147</ArticleId><ArticleId IdType="pmc">PMC4442813</ArticleId><ArticleId IdType="pubmed">26008742</ArticleId></ArticleIdList></Reference><Reference><Citation>Armulik A. (2005). Endothelial/Pericyte Interactions. Circulation Research 97, 512&#x2013;523. 10.1161/01.RES.0000182903.16652.d7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000182903.16652.d7</ArticleId><ArticleId IdType="pubmed">16166562</ArticleId></ArticleIdList></Reference><Reference><Citation>Arturi F, Melegari G, Giansante A, Giuliani E, Bertellini E, and Barbieri A (2023). COVID-19 Biomarkers for Critically Ill Patients: A Compendium for the Physician. Neurology International 15, 881&#x2013;895. 10.3390/neurolint15030056.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurolint15030056</ArticleId><ArticleId IdType="pmc">PMC10366869</ArticleId><ArticleId IdType="pubmed">37489362</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Y-J, Liu S-H, Manachevakul S, Lee T-A, Kuo C-T, and Bello D (2023). Biomarkers in long COVID-19: A systematic review. Front. Med 10, 1085988. 10.3389/fmed.2023.1085988.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1085988</ArticleId><ArticleId IdType="pmc">PMC9895110</ArticleId><ArticleId IdType="pubmed">36744129</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellon M, Schweblin C, Lambeng N, Cherpillod P, Vazquez J, Lalive PH, Schibler M, and Deffert C (2021). Cerebrospinal Fluid Features in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reverse Transcription Polymerase Chain Reaction (RT-PCR) Positive Patients. Clinical Infectious Diseases 73, e3102&#x2013;e3105. 10.1093/cid/ciaa1165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1165</ArticleId><ArticleId IdType="pmc">PMC7454353</ArticleId><ArticleId IdType="pubmed">32770235</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmailian M, Vakili Z, Nasr-Esfahani M, Heydari F, and Masoumi B D-dimer Levels in Predicting Severity of Infection and Outcome in Patients with COVID-19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10423863</ArticleId><ArticleId IdType="pubmed">37583776</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui R, Mungroo MR, and Khan NA (2021). SARS-CoV-2 invasion of the central nervous: a brief review. Hospital Practice 49, 157&#x2013;163. 10.1080/21548331.2021.1887677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21548331.2021.1887677</ArticleId><ArticleId IdType="pmc">PMC7938650</ArticleId><ArticleId IdType="pubmed">33554684</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefely JA, Christensen BB, Gogakos T, Cone Sullivan JK, Montgomery GG, Barranco JP, and Van Cott EM (2020). Marked factor V activity elevation in severe COVID -19 is associated with venous thromboembolism. American J Hematol 95, 1522&#x2013;1530. 10.1002/ajh.25979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25979</ArticleId><ArticleId IdType="pmc">PMC7461432</ArticleId><ArticleId IdType="pubmed">32833259</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene C, Connolly R, Brennan D, Laffan A, O&#x2019;Keeffe E, Zaporojan L, Connolly E, Cheallaigh CN, Conlon N, Doherty C, et al. (2023). Blood-brain barrier disruption in Long COVID-associated cognitive impairment (In Review) 10.21203/rs.3.rs-2069710/v2.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-2069710/v2</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler ES, Bailey AL, Kafai NM, Nair S, McCune BT, Yu J, Fox JM, Chen RE, Earnest JT, Keeler SP, et al. (2020). SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat Immunol 21, 1327&#x2013;1335. 10.1038/s41590-020-0778-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0778-2</ArticleId><ArticleId IdType="pmc">PMC7578095</ArticleId><ArticleId IdType="pubmed">32839612</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong W, Mead H, Tian L, Park J-G, Garcia JI, Jaramillo S, Barr T, Kollath DS, Coyne VK, Stone NE, et al. (2022). The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus. J Virol 96, e00964&#x2013;21. 10.1128/JVI.00964-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00964-21</ArticleId><ArticleId IdType="pmc">PMC8754221</ArticleId><ArticleId IdType="pubmed">34668775</ArticleId></ArticleIdList></Reference><Reference><Citation>Puhach O, Meyer B, and Eckerle I (2022). SARS-CoV-2 viral load and shedding kinetics. Nat Rev Microbiol. 10.1038/s41579-022-00822-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00822-w</ArticleId><ArticleId IdType="pmc">PMC9716513</ArticleId><ArticleId IdType="pubmed">36460930</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y-C, Malott RJ, Ward L, Kiplagat L, Pabbaraju K, Gill K, Berenger BM, Hu J, Fonseca K, Noyce RS, et al. (2022). Detection and quantification of infectious severe acute respiratory coronavirus-2 in diverse clinical and environmental samples. Sci Rep 12, 5418. 10.1038/s41598-022-09218-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-09218-5</ArticleId><ArticleId IdType="pmc">PMC8967087</ArticleId><ArticleId IdType="pubmed">35354854</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukagoshi H, Shinoda D, Saito M, Okayama K, Sada M, Kimura H, and Saruki N (2021). Relationships between Viral Load and the Clinical Course of COVID-19. Viruses 13, 304. 10.3390/v13020304.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020304</ArticleId><ArticleId IdType="pmc">PMC7919281</ArticleId><ArticleId IdType="pubmed">33672005</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S, Haferkamp U, Pfefferle S, Woo MS, Heinrich F, Schweizer M, Appelt-Menzel A, Cubukova A, Barenberg J, Leu J, et al. (2022). The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. Stem Cell Reports 17, 307&#x2013;320. 10.1016/j.stemcr.2021.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.12.011</ArticleId><ArticleId IdType="pmc">PMC8772030</ArticleId><ArticleId IdType="pubmed">35063125</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel J, Lampe J, M&#xfc;ller-Fielitz H, Schuster R, Zille M, M&#xfc;ller K, Krohn M, K&#xf6;rbelin J, Zhang L, &#xd6;zorhan &#xdc;, et al. (2021). The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nat Neurosci 24, 1522&#x2013;1533. 10.1038/s41593-021-00926-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00926-1</ArticleId><ArticleId IdType="pmc">PMC8553622</ArticleId><ArticleId IdType="pubmed">34675436</ArticleId></ArticleIdList></Reference><Reference><Citation>Deffner F, Scharr M, Klingenstein S, Klingenstein M, Milazzo A, Scherer S, Wagner A, Hirt B, Mack AF, and Neckel PH (2020). Histological Evidence for the Enteric Nervous System and the Choroid Plexus as Alternative Routes of Neuroinvasion by SARS-CoV2. Front Neuroanat 14, 596439. 10.3389/fnana.2020.596439.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnana.2020.596439</ArticleId><ArticleId IdType="pmc">PMC7573115</ArticleId><ArticleId IdType="pubmed">33122999</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, Fehlmann T, Stein JA, Schaum N, Lee DP, et al. (2021). Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature 595, 565&#x2013;571. 10.1038/s41586-021-03710-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MH, Perl DP, Steiner J, Pasternack N, Li W, Maric D, Safavi F, Horkayne-Szakaly I, Jones R, Stram MN, et al. (2022). Neurovascular injury with complement activation and inflammation in COVID-19. Brain 145, 2555&#x2013;2568. 10.1093/brain/awac151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac151</ArticleId><ArticleId IdType="pmc">PMC9278212</ArticleId><ArticleId IdType="pubmed">35788639</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwabenland M, Sali&#xe9; H, Tanevski J, Killmer S, Lago MS, Schlaak AE, Mayer L, Matschke J, P&#xfc;schel K, Fitzek A, et al. (2021). Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity 54, 1594&#x2013;1610.e11. 10.1016/j.immuni.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8188302</ArticleId><ArticleId IdType="pubmed">34174183</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramlall V, Thangaraj PM, Meydan C, Foox J, Butler D, Kim J, May B, De Freitas JK, Glicksberg BS, Mason CE, et al. (2020). Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection. Nat Med 26, 1609&#x2013;1615. 10.1038/s41591-020-1021-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1021-2</ArticleId><ArticleId IdType="pmc">PMC7809634</ArticleId><ArticleId IdType="pubmed">32747830</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzzi S, Tsitsou-Kampeli A, and Schwartz M (2023). The type I interferon antiviral response in the choroid plexus and the cognitive risk in COVID-19. Nat Immunol 24, 220&#x2013;224. 10.1038/s41590-022-01410-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01410-z</ArticleId><ArticleId IdType="pubmed">36717725</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>